The Research & Authority Newsletter

Mar. 13, 2024    

 

 

 
 

 

Calls for Proposals

 

Transforming Health and Care Systems (THCS)
                                             
ERA-NET: Innovate to Prevent: Personalized Prevention in Health and Care Service

The call aims to fund projects that implement personalized prevention strategies in health and care services, emphasizing person-centered approaches and the use of IT and digital technologies. 
Its goal is to enhance various aspects of health and care systems, such as quality, efficiency, equity, and sustainability, ultimately improving citizens' quality of life while reducing the burden on services.

Budget: € 140,000 total.

Eligibility: Requires a consortium of 3-9 partners from the list of eligible countries.

Duration: 3 years.

Funding Agency: Israeli PI's are funded by the Chief Scientist Office of The Ministry of Health (CSO-MOH).


RDA Contact: Vered Kedar, Tel: 64 72435

Mandatory Registration, Apr 14, 2024

Full Proposals, May 7, 2024

 

Ministry of Innovation, Science and Technology (MOST)
                                             
M-era.Net 2024

M-ERA.Net, a European initiative, supports partnerships in materials science and batteries to align with the European policy on greenhouse gas reduction. It fosters coordination between research programs, offering funding through consortia of countries and global funding organizations.

Focus Areas for This Call:

1. Sustainable advanced materials for energy
2. Innovative surfaces, coatings and interfaces
3. High performance composites
4. Functional materials
5. Materials addressing environmental challenges
6. Next-generation materials for advanced electronics

Budget: € 100,000 total.  

Eligibility: Requires a consortium of 3-9 partners from the list of eligible countries.

Funding Agency: Israeli PI's are funded by the Chief Scientist Office of The Ministry of Health (CSO-MOH). 

Duration: 3 years.


RDA Contact: Vered Kedar, Tel: 64 72435 

LOI, May 12, 2024

 

Pfizer – Global Medical Grants
                                             
Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections

The call seeks proposals to enhance healthcare professional education on diagnosing Metallo-β-Lactamase (MBL) producing bacterial infections. It aims to address knowledge gaps and develop educational tools/programs for improved patient management. 

Budget: $ 100,000 total.  


RDA Contact : Yaara Hazan, Tel: 64 77748

Full Proposals, Apr 14, 2024

 

Juvenile Diabetes Research Foundation (JDRF)
                                             LOI: Strategic Research Agreement (SRA)

This call seeks to fund investigators addressing critical gaps in type 1 diabetes research, fostering breakthroughs through innovative scientific inquiry. The JDRF views the SRA program track as a partnership enterprise between the JDRF and the PI, with meaningful interaction between the PI and the assigned JDRF scientist (e.g. cooperative development of the research plan)

Budget: No fixed limit.  

Duration: 3 years.


RDA Contact : Yaara Hazan, Tel: 64 77748

LOI, Apr 30, 2024

 

FamilieSCN2A Foundation
                                             
LOI: Action Potential Grant

This call seeks to support early career researchers in developing innovative projects focused on advancing therapeutic treatments for SCN2A-related disorders. It aims to facilitate breakthroughs in understanding and addressing these disorders through funding and guidance.

Budget: $ 75,000 total.

Duration: 1 years.


RDA Contact : Yaara Hazan, Tel: 64 77748

LOI, Mar 27, 2024

 

Other

 

BIO Innovation Unit – RDA Grant Support *NEW*
                                             
Increase chances of winning a grant
and potential for future commercialization

If you are considering or in the process of writing a grant for a project with potential commercial applications in the BIO field, feel free to approach our unit for support and direction.

BIO field includes:
Pharma, Biotechnology, Diagnostics, Medical Device, Digital Health 

Our support includes:
•Assistance with defining the future product in terms of market needs, competitor and market analysis, business model etc.

•Defining important research milestones that can increase the potential for future commercialization.

*This is a service offered in collaboration with RDA*


BGN Contact – Head of Bio Innovation Unit: Dr. Anat Shperberg-Avni, Tel: 054-786-6084

 

Grant Awardees

 

The British Council (BIRAX)

- Prof. Raz Jelinek, Dept. of Chemistry

 

 

נשלח באמצעות smoove פלטפורמת שיווק